3D Mammogram (Breast Tomosynthesis) in Houston

The Latest Technology for Early Detection

About Tomosynthesis

Breast tomosynthesis is an innovative new, FDA-approved digital technology that helps physicians detect smaller tumors sooner -- at the earliest stages of breast cancer.

The 3-D imaging technology of tomosynthesis enables radiologists to see "inside" the breast. This reduces or eliminates problems caused by dense tissue overlapping.

Do I Qualify for 3D Mammogram?

Breast tomosynthesis is available immediately to patients who are due for their yearly screening mammogram.

What to Expect During a 3D Mammogram

Tomosynthesis takes 15 successive images at slightly different angles across the breast, resulting in improved accuracy in screening results and pinpointing of lesion location.

Make an Appointment

Schedule online or call 877-40-MAMMO to make an appointment for a 3D mammogram.

Schedule your 3D tomography online 24/7. Just click a time to get started. Click "next week" to see more appointment times.

Please note: If either of the following conditions apply to you, please contact our Central Scheduling Department at (877) 704-8700 to assist you in scheduling your procedure.

You have been diagnosed with breast cancer and/or had a mastectomy or lumpectomy within the past 2 years.
You are experiencing lumps or discharge from your breasts.

Because this technology is not yet covered by most insurance companies, Memorial Hermann will bill your insurance for a 2-D digital mammogram and charge an additional $50 for tomosynthesis.

appointments powered by HealthPost

Breast Tomosynthesis in the News

Memorial Hermann is the first hospital system in South Texas to offer breast tomosynthesis, a 3-D mammogram that enables radiologists to see “inside” the breast. Physicians say this cutting-edge digital technology will help them detect smaller tumors at the earliest stages of breast cancer, potentially saving the lives of hundreds of women.

About the Clinical Trials

Clinical trials using the Dimensions 3-D system showed measurable improvement in clinical performance over conventional mammography. The trials also showed significant gains in specificity - the confidence to rule out cancer without recalling the patient for further study - and other benefits, including improved lesion and margin visibility and the ability to accurately localize structures in the breast.

Stephen Rose, M.D., breast radiologist affiliated with Memorial Hermann, was the principal investigator of last year’s breast Tomosynthesis clinical trial at Memorial Hermann Memorial City that paved the way for the technology being approved.